SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance
Highlights•SOX9 dysregulation positively correlates with cancer progression and drug
resistance.•SOX9 is a promising molecular target for cancer therapeutics.•SOX9 expression …
resistance.•SOX9 is a promising molecular target for cancer therapeutics.•SOX9 expression …
Deep learning based on hematoxylin–eosin staining outperforms immunohistochemistry in predicting molecular subtypes of gastric adenocarcinoma
N Flinner, S Gretser, A Quaas, K Bankov… - The journal of …, 2022 - Wiley Online Library
In gastric cancer (GC), there are four molecular subclasses that indicate whether patients
respond to chemotherapy or immunotherapy, according to the TCGA. In clinical practice …
respond to chemotherapy or immunotherapy, according to the TCGA. In clinical practice …